VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

SOHO 2022 | The prognostic and therapeutic implications of MRD in AML

Nicholas Short, MD, University of Texas MD Anderson Cancer Center, Houston, TX, shares some insights into the important prognostic and therapeutic implications of measurable residual disease (MRD) in acute myeloid leukemia (AML). Dr Short first discusses the various markers that are used in MRD monitoring, and then goes on to highlight the value of using MRD status when making therapeutic decisions. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter